AAAAAA
Results: 1-25/41
Authors:
Ojo, AO
Hanson, JA
Meier-Kriesche, HU
Okechukwu, CN
Wolfe, RA
Leichtman, AB
Agodoa, LY
Kaplan, B
Port, FK
Citation: Ao. Ojo et al., Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates, J AM S NEPH, 12(3), 2001, pp. 589-597
Authors:
Wolfe, RA
Held, PJ
Port, FK
Citation: Ra. Wolfe et al., Calculation and public use of the unit-specific standardized mortality ratio, AM J KIDNEY, 38(1), 2001, pp. 212-213
Authors:
Wolfe, RA
Held, PJ
Port, FK
Citation: Ra. Wolfe et al., Calculation and public use of the unit-specific standardized mortality ratio, AM J KIDNEY, 38(1), 2001, pp. 214-215
Authors:
Port, FK
Wolfe, RA
Hulbert-Shearon, TE
Daugirdas, JT
Agodoa, LYC
Jones, C
Orzol, SM
Held, PJ
Citation: Fk. Port et al., Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study, AM J KIDNEY, 37(2), 2001, pp. 276-286
Authors:
Ojo, AO
Meier-Kriesche, HU
Arndorfer, JA
Leichtman, AB
Magee, JC
Cibrik, DM
Wolfe, RA
Port, FK
Agodoa, L
Kaufman, DB
Kaplan, B
Citation: Ao. Ojo et al., Long-term benefit of kidney-pancreas transplants in Type 1 diabetics, TRANSPLAN P, 33(1-2), 2001, pp. 1670-1672
Authors:
Ojo, AO
Meier-Kriesche, HU
Hanson, JA
Leichtman, A
Magee, JC
Cibrik, D
Wolfe, RA
Port, FK
Agodoa, L
Kaufman, DB
Kaplan, B
Citation: Ao. Ojo et al., The impact of simultaneous pancreas-kidney transplantation on long-term patient survival, TRANSPLANT, 71(1), 2001, pp. 82-90
Authors:
Moist, LM
Port, FK
Orzol, SM
Young, EW
Ostbye, T
Wolfe, RA
Hulbert-Shearon, T
Jones, CA
Bloembergen, WE
Citation: Lm. Moist et al., Predictors of loss of residual renal function among new dialysis patients, J AM S NEPH, 11(3), 2000, pp. 556-564
Authors:
Okechukwu, CN
Orzol, SM
Held, PJ
Pereira, BJG
Agodoa, LYC
Wolfe, RA
Port, FK
Citation: Cn. Okechukwu et al., Characteristics and treatment of patients not reusing dialyzers in reuse units, AM J KIDNEY, 36(5), 2000, pp. 991-999
Authors:
Wolfe, RA
Ashby, VB
Milford, EL
Bloembergen, WE
Agodoa, LYC
Held, PJ
Port, FK
Citation: Ra. Wolfe et al., Differences in access to cadaveric renal transplantation in the United States, AM J KIDNEY, 36(5), 2000, pp. 1025-1033
Authors:
Ojo, AO
Leichtman, AB
Punch, JD
Hanson, JA
Dickinson, DM
Wolfe, RA
Port, FK
Agodoa, LY
Citation: Ao. Ojo et al., Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes, AM J KIDNEY, 36(1), 2000, pp. 153-159
Authors:
Maisonneuve, P
Agodoa, L
Gellert, R
Stewart, JH
Buccianti, G
Lowenfels, AB
Wolfe, RA
Jones, E
Disney, APS
Briggs, D
McCredie, M
Boyle, P
Citation: P. Maisonneuve et al., Incidence and spectrum of dialysis-associated cancer in three continents -Author's reply, AM J KIDNEY, 35(2), 2000, pp. 352-353
Authors:
Wolfe, RA
Ashby, VB
Daugirdas, JT
Agodoa, LYC
Jones, CA
Port, FK
Citation: Ra. Wolfe et al., Body size, dose of hemodialysis, and mortality, AM J KIDNEY, 35(1), 2000, pp. 80-88
Authors:
Maisonneuve, P
Agodoa, L
Gellert, R
Stewart, JH
Buccianti, G
Lowenfels, AB
Wolfe, RA
Jones, E
Disney, APS
Briggs, D
McCredie, M
Boyle, P
Citation: P. Maisonneuve et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study, AM J KIDNEY, 35(1), 2000, pp. 157-165
Authors:
Port, FK
Wolfe, RA
Citation: Fk. Port et Ra. Wolfe, Optimizing the dialysis dose with consideration of patient size, BLOOD PURIF, 18(4), 2000, pp. 295-297
Authors:
Wolfe, RA
Citation: Ra. Wolfe, Observational studies are just as effective as randomized clinical trials, BLOOD PURIF, 18(4), 2000, pp. 323-326
Authors:
Leavey, SF
Strawderman, RL
Young, EW
Saran, R
Roys, E
Agodoa, LYC
Wolfe, RA
Port, FK
Citation: Sf. Leavey et al., Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients, KIDNEY INT, 58(5), 2000, pp. 2119-2128
Authors:
Wolfe, RA
Citation: Ra. Wolfe, Statistical analysis, a necessity for observational studies, KIDNEY INT, 57, 2000, pp. S14-S18
Authors:
Young, EW
Goodkin, DA
Mapes, DL
Port, FK
Keen, ML
Chen, K
Maroni, BL
Wolfe, RA
Held, PJ
Citation: Ew. Young et al., The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, KIDNEY INT, 57, 2000, pp. S74-S81
Authors:
Ojo, AO
Hanson, JA
Wolfe, RA
Leichtman, AB
Agodoa, LY
Port, FK
Citation: Ao. Ojo et al., Long-term survival in renal transplant recipients with graft function, KIDNEY INT, 57(1), 2000, pp. 307-313
Authors:
Ojo, AO
Meier-Kriesche, HU
Hanson, JA
Leichtman, AB
Cibrik, D
Magee, JC
Wolfe, RA
Agodoa, LY
Kaplan, B
Citation: Ao. Ojo et al., Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection, TRANSPLANT, 69(11), 2000, pp. 2405-2409
Authors:
Port, FK
Wolfe, RA
Held, PJ
Citation: Fk. Port et al., Ownership of dialysis facilities and patients' survival, N ENG J MED, 342(14), 2000, pp. 1053-1054
Authors:
Wolfe, RA
Ashby, VB
Port, FK
Citation: Ra. Wolfe et al., Mortality among patients on dialysis, patients on dialysis awaiting transplantation, and transplant recipients - Reply, N ENG J MED, 342(12), 2000, pp. 894-894
Authors:
Rahim, MA
Wolfe, RA
Citation: Ma. Rahim et Ra. Wolfe, Innovation and conflict management, CUR T MANAG, 5, 2000, pp. 247-262
Good news, bad news for diabetic versus nondiabetic end-stage renal disease: Incidence and mortality
Authors:
Wolfe, RA
Port, FK
Citation: Ra. Wolfe et Fk. Port, Good news, bad news for diabetic versus nondiabetic end-stage renal disease: Incidence and mortality, ASAIO J, 45(3), 1999, pp. 117-118
Authors:
Wolfe, RA
Port, FK
Citation: Ra. Wolfe et Fk. Port, Separating the effects of hemodialysis dose and nutrition: In search of the optimal dialysis dose, SEMIN DIAL, 12, 1999, pp. S29-S32